METAGENOMI INC. - COM

Metagenomi to Present at Chardan's 8th Annual Genetic Medicines Conference

19 Sep 2024 18:15:11 By Nasdaq GlobeNewswire

Metagenomi Announces Preclinical Data for Lead Hemophilia A Program Demonstrating Durable Factor VIII (FVIII) Activity Levels through Twelve Months

03 Sep 2024 15:05:00 By Nasdaq GlobeNewswire

Metagenomi Presents AI-Enabled Advancements of SMART Editing Platform at the Cold Spring Harbor Laboratory CRISPR Frontiers Conference

29 Aug 2024 18:32:08 By Nasdaq GlobeNewswire

Metagenomi to Participate in Upcoming Investor Conferences

28 Aug 2024 17:10:18 By Nasdaq GlobeNewswire

Metagenomi Reports Business Updates and Second Quarter 2024 Financial Results

14 Aug 2024 07:05:00 By Nasdaq GlobeNewswire

Metagenomi to Present at the 2024 Jefferies Global Healthcare Conference

29 May 2024 15:00:00 By Nasdaq GlobeNewswire

Metagenomi Presents Data at Scientific Conferences and First Quarter 2024 Financial Results

14 May 2024 15:05:00 By Nasdaq GlobeNewswire

Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems

01 May 2024 15:00:00 By Nasdaq GlobeNewswire

Metagenomi to Present at Upcoming Scientific Meetings

08 Apr 2024 07:00:00 By Nasdaq GlobeNewswire

Metagenomi Reports Business Updates and Full Year 2023 Financial Results

27 Mar 2024 08:16:21 By Nasdaq GlobeNewswire

Metagenomi to Participate in the 44th Annual Cowen Healthcare Conference

29 Feb 2024 15:30:00 By Nasdaq GlobeNewswire

Metagenomi Announces Closing of Initial Public Offering

13 Feb 2024 15:35:00 By Nasdaq GlobeNewswire